Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

This is just Mac selling off the last bit of value from Onko Sure. He attempted to sell off the production technology to GCDX and now is attempting to sell it off to UNI. Note that Radient only gets $20,000 until a successful commercial-scale production trial run is made by UNI manufacturing DR-70.


"The total fee for UNI’s five year Onko-Sure DR-70 license is five hundred thousand dollars ($500,000) USD to be paid out annually as per Paragraph 1.2 in Exhibit B below. UNI shall pay up-front (the “Up-Front License Fee) one hundred thousand dollars ($100,000) to RXPC in two installments: twenty thousand USD ($20,000) will be wired upon co-signing of the License Agreement with the remaining eighty thousand ($80,000) to be wired to RXPC after tech transfer training and commercial-scale trial-run production for Onko-Sure (DR-70) from RXPC. This License Agreement will become effective upon receipt of the up-front license fee to RXPC. "